Question:In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression of diabetic kidney disease.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.

View a FreeCLINICAL ANSWER